Dna Group (T.R.) Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
DNA
IL0011038523
Biotechnology & Medical Research
Sales 2022 | 0.56 2.11 | Sales 2023 | 0.31 1.15 | Capitalization | 77.84M 293M |
---|---|---|---|---|---|
Net income 2022 | -23M -86.68M | Net income 2023 | -1M -3.77M | EV / Sales 2022 | 38,063,516 x |
Net cash position 2022 | 65.73M 248M | Net cash position 2023 | 66.7M 251M | EV / Sales 2023 | 36,410,820 x |
P/E ratio 2022 |
-3.6
x | P/E ratio 2023 |
-63.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.14% |
Managers | Title | Age | Since |
---|---|---|---|
Ori Altschuler
CEO | Chief Executive Officer | 41 | 22-01-17 |
Klein Tony Hanan
DFI | Director of Finance/CFO | 43 | 15-11-14 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 10-04-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Orit Stav
BRD | Director/Board Member | 53 | 22-10-19 |
Erez Navon
CHM | Chairman | 50 | 21-02-23 |
Ronen Midbari
BRD | Director/Board Member | 48 | 19-03-18 |
1st Jan change | Capi. | |
---|---|---|
+3.25% | 42.11B | |
+48.83% | 40.08B | |
+8.47% | 40B | |
-10.82% | 26.87B | |
+8.16% | 24.58B | |
-23.21% | 18.44B | |
+1.16% | 11.94B | |
+33.51% | 11.66B | |
+7.07% | 11.01B |